Stock Movers Boston Scientific Tumbles, Sysco Sinks, Fannie and Freddie Surges
Mar 30, 2026
Cardio device trial data falls short, sparking a sharp selloff. A huge restaurant-distribution takeover shocks investors and drags shares down. Mortgage giants roar higher after a billionaire calls them bargain-priced amid talks of relisting. Markets react with volatility and debate over conservatorship and IPO plans.
AI Snips
Chapters
Transcript
Episode notes
Watchman Trial Disappoints Boston Scientific
- Boston Scientific shares plunged after its Watchman heart implant trial results missed investor expectations.
- Leerink Partners called the data “not the home-run scenario,” and BSX is down ~34% year-to-date into 2026.
Sysco Deal Spurs Big Share Drop
- Sysco agreed to acquire Jetro Restaurant Depot in a roughly $29 billion deal including debt, triggering a sharp share decline.
- The market punished SYY with about a 15% intraday drop as investors balked at the scale and cost of the acquisition.
Ackman Sparks Rally In Fannie And Freddie
- Fannie Mae and Freddie Mac stocks surged roughly 30–40% after Bill Ackman called them “stupidly cheap.”
- The names remain volatile OTC plays tied to speculation about relisting and government conservatorship since 2008.